Indications, evolving technique, and early outcomes with robotic retroperitoneal lymph node dissection. Issue 5 (September 2018)

• Record Type: Journal Article
• Authors: Werntz, Ryan P.; Pearce, Shane M.; Eggener, Scott E.
• Is Part Of: Current opinion in urology. Volume 28:Issue 5(2018:Sep.)
• Publication Date: 2018-09
• Subjects: retroperitoneal lymph node dissection -- robotic surgery -- testicular cancer; Urology -- Periodicals; Review Literature -- Bibliography; Review Literature -- Periodicals; Male Urogenital Diseases -- Bibliography; Male Urogenital Diseases -- Periodicals; Female Urogenital Diseases -- Bibliography; Female Urogenital Diseases -- Periodicals; Urologic Diseases -- Bibliography; Urologic Diseases -- Periodicals; Periodicals; 616.6005
• DOI: 10.1097/MOU.0000000000000530
• Languages: English
• ISSNs: 1473-6586

Abstract

Abstract : Purpose of review: Examine and discuss indications, technique, and outcomes for robotic retroperitoneal lymph node dissection (RPLND) for testicular cancer. Recent findings: Open RPLND has been the longstanding standard of care for both primary and post chemotherapy RPLND. Recently, robotic RPLND has been an attractive option with the intent of reducing the morbidity associated with open surgery while providing identical oncologic efficacy. Naysayers of robotic RPLND suggest it is often inappropriately used as a staging procedure and consequently can compromise oncologic efficacy. Summary: Robotic RPLND is being evaluated as a therapeutic equivalent to open RPLND. On the basis of limited published data with modest follow-up from experienced centers, robotic RPLND appears to provide effective staging and therapeutic data mirroring that of open surgery.